North America Blood Transfusion Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Blood Transfusion Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Blood Transfusion Diagnostics Market Regional Analysis

6.2 North America Blood Transfusion Diagnostics Market Revenue 2020-2028 (US$ Million)

6.3 North America Blood Transfusion Diagnostics Market Forecast Analysis

7. North America Blood Transfusion Diagnostics Market Analysis – by Product

7.1 Instruments & Kits

7.1.1 Overview
7.1.2 Instruments & Kits: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Blood Transfusion Diagnostics Market Analysis – by Application

8.1 Blood Grouping

8.1.1 Overview
8.1.2 Blood Grouping: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Disease Screening

8.2.1 Overview
8.2.2 Disease Screening: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Blood Transfusion Diagnostics Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Diagnostic Laboratories

9.2.1 Overview
9.2.2 Diagnostic Laboratories: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Blood Banks

9.3.1 Overview
9.3.2 Blood Banks: North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Plasma Fractionation Companies

9.4.1 Overview
9.4.2 Plasma Fractionation Companies : North America Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Blood Transfusion Diagnostics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Blood Transfusion Diagnostics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Blood Transfusion Diagnostics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Blood Transfusion Diagnostics Market Breakdown, by Product
10.2.1.1.2 US: North America Blood Transfusion Diagnostics Market Breakdown, by Application
10.2.1.1.3 US: North America Blood Transfusion Diagnostics Market Breakdown, by End User

10.2.1.2 Canada: North America Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Blood Transfusion Diagnostics Market Breakdown, by Product
10.2.1.2.2 Canada: North America Blood Transfusion Diagnostics Market Breakdown, by Application
10.2.1.2.3 Canada: North America Blood Transfusion Diagnostics Market Breakdown, by End User

10.2.1.3 Mexico : North America Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Blood Transfusion Diagnostics Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Blood Transfusion Diagnostics Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Blood Transfusion Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BAG Diagnostics GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio-Rad Laboratories, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 DiaSorin S.p.A.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Grifols, S.A.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Immucor, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Quotient Limited

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Blood Transfusion Diagnostics Market

Analysis By Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)